1neuro.hut.fi/kyl2000.pdf · - 2 - magazine articles.....61 reports.....61
Clinical Research Facility at PAH - Metro South HealthFor more information contact: Todd Gumbleton...
1
For more information contact: Todd Gumbleton Clinical Nurse Consultant T +61 7 3176 8708 F +61 7 3443 7374 E [email protected] W www.tri.edu.au | www.metrosouth.health.qld.gov.au TRANSLATIONAL RESEARCH INSTITUTE AUSTRALIA The Translational Research Institute (TRI) is a leading Australian medical research facility focusing on innovative translational research. The TRI Clinical Research Facility (CRF) is located at the Princess Alexandra Hospital (PAH) and operated by Metro South Hospital and Health Service. The CRF provides state-of-the-art specialist facilities, resources and expertise for investigator led and commercially sponsored clinical trials. The clinical trials team have extensive experience in clinical trial management and coordination across multiple phases of clinical research. Benefits of utilising the CRF at the PAH include: • The use of a purpose-built facility where patient comfort is priority • Spacious, light filled rooms with a calming atmosphere • Specialist nursing staff on-site to attend patients • Temperature monitored storage for Investigational Product (IP) and Laboratory samples • Full integration with the PAH Digital Hospital • Clinical trials conducted adhering to all applicable national and international standards • Implementation planning to ensure trial will be completed efficiently • Full access to PAH emergency and medical services including rapid response team and ICU • Patient entertainment including TV and internet Clinical Research Facility at PAH CRF Resources • Observational suite • Exercise gym • Phlebotomy facilities • Vectra imaging system • Four-bed ward • Short stay rooms with recliners • Clinical nurses station • Phone booths • Sample processing laboratory • Pharmacy storage • Frozen storage • Office and open desk space • Meeting rooms • Nursing support • Secure site file storage • Linked to PAH Digital Hospital • Access to specialised imaging and genomics platforms
Transcript of Clinical Research Facility at PAH - Metro South HealthFor more information contact: Todd Gumbleton...
For more information contact:Todd GumbletonClinical Nurse ConsultantT +61 7 3176 8708F +61 7 3443 7374E [email protected] www.tri.edu.au | www.metrosouth.health.qld.gov.au
TRANSLATIONAL RESEARCH INSTITUTE
AUSTRALIA
The Translational Research Institute (TRI) is a leading Australian medical research facility focusing on innovative translational research.
The TRI Clinical Research Facility (CRF) is located at the Princess Alexandra Hospital (PAH) and operated by Metro South Hospital and Health Service.
The CRF provides state-of-the-art specialist facilities, resources and expertise for investigator led and commercially sponsored clinical trials. The clinical trials team have extensive experience in clinical trial management and coordination across multiple phases of clinical research.
Benefits of utilising the CRF at the PAH include:• The use of a purpose-built facility where patient comfort is priority• Spacious, light filled rooms with a calming atmosphere• Specialist nursing staff on-site to attend patients• Temperature monitored storage for Investigational Product (IP) and
Laboratory samples• Full integration with the PAH Digital Hospital• Clinical trials conducted adhering to all applicable national and
international standards• Implementation planning to ensure trial will be completed efficiently• Full access to PAH emergency and medical services including rapid
response team and ICU• Patient entertainment including TV and internet
Clinical Research Facility at PAH
CRF Resources• Observational suite• Exercise gym• Phlebotomy facilities• Vectra imaging system• Four-bed ward• Short stay rooms with recliners• Clinical nurses station• Phone booths• Sample processing laboratory• Pharmacy storage• Frozen storage• Office and open desk space• Meeting rooms• Nursing support • Secure site file storage• Linked to PAH Digital Hospital • Access to specialised imaging
and genomics platforms
